A Review Of ARQ 531
On this analyze we examined the activity of cefepime/zidebactam (WCK 5222) from consecutive reference laboratory submissions of Gram-adverse microbes, taken like a sample of challenge strains circulating in britain.Any actions taken by the reader determined by looking at this material is the only real obligation on the reader. None of the companies